81 related articles for article (PubMed ID: 2341895)
1. Internally administered isotopes in the treatment of solid malignancy.
Willett CG
J Nucl Med; 1990 May; 31(5):601-2. PubMed ID: 2341895
[No Abstract] [Full Text] [Related]
2. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
Krishnamurthy GT; Krishnamurthy S
J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
[No Abstract] [Full Text] [Related]
3. Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.
Lattimer JC; Corwin LA; Stapleton J; Volkert WA; Ehrhardt GJ; Ketring AR; Hewett JE; Simon J; Goeckeler WF
J Nucl Med; 1990 May; 31(5):586-93. PubMed ID: 2341893
[TBL] [Abstract][Full Text] [Related]
4. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
Jiang CY; Zhu BL; Zhang YJ
Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052
[TBL] [Abstract][Full Text] [Related]
5. Samarium-153 lexidronam for painful bone metastases.
Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284
[No Abstract] [Full Text] [Related]
6. Radiopharmaceuticals in clinical trials.
Holmes RA
Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
[TBL] [Abstract][Full Text] [Related]
7. Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
Singh A; Holmes RA; Farhangi M; Volkert WA; Williams A; Stringham LM; Ketring AR
J Nucl Med; 1989 Nov; 30(11):1814-8. PubMed ID: 2478681
[TBL] [Abstract][Full Text] [Related]
8. Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.
Lattimer JC; Corwin LA; Stapleton J; Volkert WA; Ehrhardt GJ; Ketring AR; Anderson SK; Simon J; Goeckeler WF
J Nucl Med; 1990 Aug; 31(8):1316-25. PubMed ID: 2384798
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide targeting of bone metastases: which efficacy?
Leyvraz S; Burckhardt P
J Clin Oncol; 1990 Sep; 8(9):1598-9. PubMed ID: 2391559
[No Abstract] [Full Text] [Related]
10. New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
Williams JE
J Nucl Med; 1997 Nov; 38(11):19N-20N, 26N. PubMed ID: 9374327
[No Abstract] [Full Text] [Related]
11. Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
Scher HI; Curley T; Yeh S; Tong W; O'Moore PV; Larson S
Adv Exp Med Biol; 1992; 324():115-29. PubMed ID: 1283494
[No Abstract] [Full Text] [Related]
12. Bony metastases seen on scintigraphy with samarium-153.
Verma N; Singh-Wadhwa S; Chan WL
Clin Nucl Med; 2002 Mar; 27(3):207. PubMed ID: 11852311
[No Abstract] [Full Text] [Related]
13. Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor model.
Winderen M; Kjønniksen I; Fodstad O
J Natl Cancer Inst; 1995 Feb; 87(3):221-2. PubMed ID: 7707409
[No Abstract] [Full Text] [Related]
14. Radionuclide therapy in oncology.
Clarke SE
Cancer Treat Rev; 1994 Jan; 20(1):51-71. PubMed ID: 8293428
[No Abstract] [Full Text] [Related]
15. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.
Sartor O; Reid RH; Hoskin PJ; Quick DP; Ell PJ; Coleman RE; Kotler JA; Freeman LM; Olivier P;
Urology; 2004 May; 63(5):940-5. PubMed ID: 15134985
[TBL] [Abstract][Full Text] [Related]
16. Cancer therapy using bone-seeking isotopes.
Lewington VJ
Phys Med Biol; 1996 Oct; 41(10):2027-42. PubMed ID: 8912378
[TBL] [Abstract][Full Text] [Related]
17. [Effect of 153Sm-EDTMP on hematopoiesis and vital organs of 93 patients with bone tumor].
Deng H; Tan T; Mo T; Zhong S; Kuan A; Hu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):155-9. PubMed ID: 7490021
[TBL] [Abstract][Full Text] [Related]
18. Samarium-153-EDTMP dosimetry.
Heggie JC
J Nucl Med; 1994 Jan; 35(1):191-2. PubMed ID: 8271053
[No Abstract] [Full Text] [Related]
19. Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium.
Porter AT; Ben-Josef E; Davis L
Curr Opin Oncol; 1994 Nov; 6(6):607-10. PubMed ID: 7827173
[TBL] [Abstract][Full Text] [Related]
20. Hemodialysis in a patient being treated with 153Sm.
Murphy PH; Ford PV
J Nucl Med; 2001 Feb; 42(2):391. PubMed ID: 11216541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
